newsfilter
← Latest News
GlobeNewswire·

Trillium Announces Voting Results From the Annual and Special Meeting of Shareholders

CAMBRIDGE, Mass., July 06, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) (the “Corporation”), a clinical stage immuno-oncology company developing innovative therapies for...